Pharmacokinetic Study Comparing Two Salmeterol Fluticasone Propionate Device-metered Dry Powder Inhalers, Salmeterol/Fluticasone Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; a Randomised, Double blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects

Trial Profile

Pharmacokinetic Study Comparing Two Salmeterol Fluticasone Propionate Device-metered Dry Powder Inhalers, Salmeterol/Fluticasone Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; a Randomised, Double blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2014

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary) ; Charcoal
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacokinetics
  • Sponsors Orion
  • Most Recent Events

    • 16 Jan 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 23 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top